败毒散治疗呼吸系统疾病的研究进展  

Research Progress on the Treatment of Respiratory System Diseases with Baidu Powder

作　　者：肖世伟 李金飞 朱亚楠 苏玉杰 

机构地区：[1]云南中医药大学第一临床医学院,云南 昆明

出　　处：《临床医学进展》2024年第9期1093-1099,共7页Advances in Clinical Medicine

摘　　要：败毒散又名人参败毒散、羌活汤、十味汤、人参前胡散,最早记载于宋代《太平惠民和剂局方》卷二,吴昆所著《医方考》云:“培其正气,败其毒邪,故曰败毒”,临床上曾广泛应用于治疗疫病。后世医家基于中医辨证及相关研究,将该方剂运用于其他呼吸系统疾病的治疗亦取得较好的临床疗效。通过查阅、分析、整理相关文献,综述败毒散的组方用药、药理学研究、分子机制研究,以及在呼吸系统疾病中的临床应用,旨在为败毒散的临床应用和后续深入研究提供参考。Baidu San, also known as Renshen Baidu San, Qianghuo Tang, Shiwei Tang, and Renshen Qianhu San, was first recorded in Volume II of Song Dynasty’s “Taiping Huimin Heji Jufang” (Bureau of Medical Administration for the Benefit of the People). Wu Kun’s “Yi Fang Kao” (Examination of Medical Formulas) states: “It cultivates the body’s vital qi and eliminates pathogenic toxins, hence the name ‘Baidu’ (eliminating toxins).” This formula is widely used clinically in the treatment of influenza. Based on traditional Chinese medicine syndrome differentiation and modern pharmacological research, later generations of doctors have applied this formula to the treatment of respiratory diseases and achieved good clinical results. Through reviewing, analyzing, and organizing relevant literature, this article summarizes the composition, pharmacological research, molecular mechanism research, and clinical application of Baidu San in respiratory diseases, aiming to provide references for the clinical application and subsequent in-depth research of Baidu San.

关 键 词：败毒散 呼吸系统疾病 研究进展 

分 类 号：R28[医药卫生—中药学]